School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
J Craniomaxillofac Surg. 2021 Jul;49(7):570-583. doi: 10.1016/j.jcms.2021.04.014. Epub 2021 Apr 29.
This study aimed to determine the effectiveness of hemostatic protocols to prevent bleeding in dental procedures among individuals undergoing oral anticoagulation therapy. A systematic review and network meta-analysis were accomplished. Searches of literature and grey literature were performed in different electronic databases. Clinical trials were considered as part of the inclusion criteria. Data extraction and assessment of the risk of bias of the included articles were performed. Assessment of the certainty of evidence was also performed. As results we find that the N-butyl-2-cyanoacrylate [RR -35.00 (95% CI - 107.12, -5.78)], calcium sulfate (CaSO) [RR -5.62 (95% CI -11.41, -1.03)], and tranexamic acid (TXA) [RR -3.46 (95% CI -7.63, -0.77)] showed beneficial effects compared to placebo. However, only TXA presented beneficial effects with moderate certainty evidence. N-butyl-2-cyanoacrylate and CaSO presented very low certainty evidence. In the comparisons between the hemostatic agents, no differences were observed. For the mean bleeding time, no significant difference in the comparisons was observed as well. Concluding, bleeding events in individuals on oral anticoagulation decreased with the use of TXA compared to placebo. N-butyl-2-cyanoacrylate and CaSO were also superior to placebo, but the certainty of evidence was low. For the mean bleeding time, no significant difference in hemostatic agents was observed.
本研究旨在确定止血方案在接受口服抗凝治疗的个体的牙科手术中预防出血的有效性。进行了系统评价和网络荟萃分析。在不同的电子数据库中进行了文献和灰色文献的检索。临床试验被认为是纳入标准的一部分。对纳入文章的风险偏倚进行了数据提取和评估。还进行了证据确定性的评估。结果表明,与安慰剂相比,正丁基-2-氰基丙烯酸酯[RR -35.00(95%CI-107.12,-5.78)]、硫酸钙(CaSO)[RR -5.62(95%CI-11.41,-1.03)]和氨甲环酸(TXA)[RR -3.46(95%CI-7.63,-0.77)]具有有益效果。然而,只有 TXA 具有中度确定性证据的有益效果。正丁基-2-氰基丙烯酸酯和 CaSO 呈现出极低的确定性证据。在止血剂的比较中,未观察到差异。对于平均出血时间,在比较中也未观察到显著差异。结论,与安慰剂相比,接受口服抗凝治疗的个体的出血事件减少了 TXA 的使用。正丁基-2-氰基丙烯酸酯和 CaSO 也优于安慰剂,但证据确定性较低。对于平均出血时间,未观察到止血剂之间有显著差异。